Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Buprenorphine vs Morphine for Severe Pain in ED
NCT03256487Phase 2Unknown
- Sponsor
- Alameda Health System
- Start
- Sep 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine extended-release injection in acute pain, sponsored by Alameda Health System. Status: unknown.
02
Drugs
buprenorphine extended-release injection
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03256487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03256487.